在患者中评估具有混合特征的抑郁症和双极性查
Erhan Akinci1, Sehnaz Basaran2, Halil İbrahim Tas3
1Department of Psychiatry, Canakkale Onsekiz Mart University School of Medicine, Çanakkale, Turkey.
Psychiatry and clinical psychopharmacology
|December 2, 2024
概括
在患者中,混合特征抑郁症 (MXD) 是常见的,这表明双极性疾病的风险更高. 对MXD的早期临床评估对于在患者中识别双相情感障碍至关重要.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 是一种慢性神经系统疾病,与各种精神疾病相关.
- 混合特征抑郁症 (MXD) 和双相情感障碍在临床管理中构成重大挑战.
- 了解和情绪障碍之间的相互作用对于改善患者的治疗结果至关重要.
研究的目的:
- 在患者中调查混合特征 (MXD) 抑郁症的患病率.
- 评估这种患者群体中双极性疾病的风险.
- 探索中临床变量和情绪障碍之间的关联.
主要方法:
- 研究了一组62名患者,随访时间至少为2年.
- 人口和临床数据是通过采访收集的.
- 经过验证的调查问卷包括修改后的低迷症检查清单 (mHCL),贝克抑郁症清单 (BDI) 和情绪障碍问卷 (MDQ) 进行了管理.
主要成果:
- 40.3%的患者表现出抑郁症 (BDI) 的迹象,9.7%表示潜在的双相情感障碍 (MDQ).
- 32.2%的人报告至少有3个躁狂症状,14.5%的人有暗示混合抑郁症 (mHCL) 的症状.
- 在BDI和mHCL得分之间,以及mHCL和MDQ得分之间发现了显著的正相关性. 与部分性相比,通用性与双极性疾病的风险更高有关.
结论:
- 在患者中,混合特征的抑郁症很普遍.
- 患者表现出双极性障碍的风险较高.
- 对MXD的临床评估对于识别患者的双极性疾病至关重要.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
605
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
11.1K
相关概念视频
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Bipolar Disorder
54
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
54
Mania and Antimanic Drugs: Overview
135
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
135
Depression: Overview
215
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
215
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
